| abstract |
A substituted norbornylamino derivative having exo-configured nitrogen and an endo-fused five-, six- or seven-membered ring of the formula I or having exo-configured nitrogen and an exo-fused five-, six- or seven-membered ring of the formula Ia; a process for preparing the compound; and the use of the compound for the production of a medicament for the treatment or prophylaxis of respiratory disorders, in particular sleep-related respiratory disorders such as sleep apneas, of acute or chronic renal disorders such as acute kidney failure or chronic kidney failure, of snoring; of impaired intestinal function, of impaired gallbladder function, of ischemic states of the peripheral and central nervous system and of stroke, of ischemic states of peripheral organs and limbs, of states of shock, of impaired lipid metabolism, of infestation by ectoparasites, for use in surgical interventions and organ transplants, for the preservation and storage of transplants for surgical interventions and for the treatment of diseases whose primary or secondary cause is cell proliferation. |